US 12,268,806 B2
Systems and methods for delivering prescribed wound therapy
Edward Yerbury Hartwell, Hull (GB); and Felix Clarence Quintanar, Hull (GB)
Assigned to T.J.Smith and Nephew, Limited, Hull (GB)
Filed by T.J.Smith and Nephew, Limited, Hull (GB)
Filed on Oct. 23, 2023, as Appl. No. 18/382,877.
Application 18/382,877 is a continuation of application No. 17/416,385, granted, now 11,793,924, previously published as PCT/EP2019/084611, filed on Dec. 11, 2019.
Claims priority of application No. 1820668 (GB), filed on Dec. 19, 2018.
Prior Publication US 2024/0131248 A1, Apr. 25, 2024
Prior Publication US 2024/0226414 A9, Jul. 11, 2024
This patent is subject to a terminal disclaimer.
Int. Cl. A61M 1/00 (2006.01); G16H 20/40 (2018.01)
CPC A61M 1/90 (2021.05) [A61M 2205/18 (2013.01); A61M 2205/35 (2013.01); A61M 2205/3553 (2013.01); A61M 2205/502 (2013.01); G16H 20/40 (2018.01)] 20 Claims
OG exemplary drawing
 
1. A negative pressure wound therapy device comprising:
a negative pressure source configured to be fluidically connected to a dressing positioned over a wound, the negative pressure source further configured to provide a negative pressure therapy to the wound; and
a controller configured to:
operate the negative pressure source to provide the negative pressure therapy to the wound in accordance with a default therapy prescription;
prior to switching a therapy prescription for the negative pressure therapy from the default therapy prescription to an updated therapy prescription different from the default therapy prescription, cause a remote computer to determine, based on a usage data associated with provision of the negative pressure therapy over a time duration, compliance of the provision of the negative pressure therapy over at least a portion of the time duration with the updated therapy prescription;
receive an indication from the remote computer that the provision of the negative pressure therapy over at least the portion of the time duration was noncompliant with the updated therapy prescription;
in response to receipt of the indication, receive an authorization to switch the therapy prescription from the default therapy prescription to the updated therapy prescription; and
in response to receipt of the authorization, operate the negative pressure source to provide the negative pressure therapy in accordance with the updated therapy prescription.